Additionally, deregulation of miRNA92a expression has been implicated in hepatocellular carcinoma [39], and, in breast cancer, estrogen receptor expression was reported to be regulated by miRNA92a [40]. This evidence concerns the gene ESR1 and breast carcinoma.